Physician
Davenport Pediatrics
Davenport Pediatrics was paid $8.00M by Medicaid between Jan 2019 and Dec 2024, across 51 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 38% of everything it billed.
33Billing provider infoDAVENPORT PEDIATRICS
DAVENPORT, FL 33837
DAVENPORT, FL 33837
33aNPI1558403691assigned 02/13/2007
33bProvider typePediatrics Physician
28Total paid$8.00M
24GClaims209,216
24DCodes billed51
24AFirst – last monthJan 2019 – Dec 2024
Compared with peers
Next to other Pediatrics Physician providers in Florida
Rank by total paid#28 of 971
Median peer was paid$238K
This provider vs. median34×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 27,841 | $793K | |
| 2020 | 28,490 | $1.14M | |
| 2021 | 32,294 | $1.57M | |
| 2022 | 45,636 | $1.93M | |
| 2023 | 47,966 | $1.63M | |
| 2024incomplete | 26,989 | $935K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 38% | 28,596 | 24,885 | $3.04M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 23% | 25,841 | 21,733 | $1.83M |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 9.4% | 6,126 | 5,916 | $752K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 8.9% | 5,698 | 5,556 | $711K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 7.6% | 5,606 | 5,525 | $605K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 5.7% | 3,909 | 3,850 | $454K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 3.3% | 17,282 | 16,832 | $263K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 11,398 | 5,474 | $78K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 4,948 | 4,731 | $71K |
| 99381 | <1% | 664 | 598 | $59K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 7,691 | 7,231 | $44K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | <1% | 122 | 120 | $19K |
39 more codes
| 85018 | <1% | 18,884 | $12K | |
| 81003 | <1% | 10,487 | $10K | |
| 99383 | <1% | 81 | $9K | |
| 86580 | <1% | 3,922 | $9K | |
| 83655 | <1% | 1,981 | $8K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 3,232 | $6K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 37 | $5K |
| 0071A | <1% | 118 | $3K | |
| 90710 | <1% | 1,241 | $2K | |
| 0072A | <1% | 50 | $2K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 418 | $1K |
| 90680 | <1% | 2,956 | $1K | |
| 90633 | <1% | 2,201 | $663.10 | |
| 90686 | <1% | 4,725 | $637.89 | |
| 0003A | <1% | 16 | $434.92 | |
| 90671 | <1% | 1,301 | $222.61 | |
| 90656 | <1% | 345 | $200.08 | |
| 36416 | <1% | 16,879 | $158.44 | |
| G0008 | Administration of influenza virus vaccine | <1% | 14 | $103.32 |
| 90651 | <1% | 1,107 | $35.00 | |
| 90700 | <1% | 336 | $28.82 | |
| 90734 | <1% | 1,137 | $24.01 | |
| 90648 | <1% | 4,469 | $12.93 | |
| G9903 | Patient screened for tobacco use and identified as a tobacco non-user | <1% | 2,002 | $6.40 |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 415 | $4.47 |
| 91307 | <1% | 183 | $0.26 | |
| 90715 | <1% | 315 | $0.12 | |
| 91300 | <1% | 39 | $0.10 | |
| 90696 | <1% | 348 | $0.04 | |
| 90723 | 0% | 3,452 | $0.00 | |
| 96127 | 0% | 1,263 | $0.00 | |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | 0% | 3,453 | $0.00 |
| 90620 | 0% | 365 | $0.00 | |
| 90716 | 0% | 30 | $0.00 | |
| 90670 | 0% | 2,990 | $0.00 | |
| G8431 | Screening for depression is documented as being positive and a follow-up plan is documented | 0% | 439 | $0.00 |
| 99173 | 0% | 13 | $0.00 | |
| 90707 | 0% | 57 | $0.00 | |
| 90685 | 0% | 34 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialKHAN, MARIA CRISTINA (CO-OWNER)